4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027011
PRESIDENT AND CEO acquired 374,013 shares (option exercise)
- PRESIDENT AND CEO acquired 8,126 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-01-16 | Option exercise | +374,013 | $0.30 | $112,204 | 1,153,544 | D |
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-06-29 | Conversion | +8,126 | 1,161,670 | D | ||
| Derivatives | |||||||
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-01-13 | Grant or award · Stock Option (right to buy) | +374,013 | 374,013 | D | ||
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-01-16 | Option exercise · Stock Option (right to buy) | −374,013 | 0 | D | ||
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-03-11 | Grant or award · Series B Preferred Stock | +19,763 | $5.06 | $100,001 | 19,763 | D |
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-03-17 | Grant or award · Stock Option (right to buy) | +795,196 | 795,196 | D | ||
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-03-17 | Grant or award · Stock Option (right to buy) | +340,798 | 340,798 | D | ||
| Lehrer-Graiwer Joshua PRESIDENT AND CEO | 2021-06-29 | Conversion · Series B Preferred Stock | −19,763 | 0 | D | ||
Loading xslF345X03/doc4.xml…